Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-09-06 4:54 pm Purchase | 13G | 2seventy bio, Inc. TSVT | Kynam Capital Management LP | 5,953,825 11.7% | 5,953,825 (New Position) | View |
| 2023-03-21 5:40 pm Sale | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management LP | 2,025,234 5% | -38,398,598 (-94.99%) | View |
| 2023-02-13 09:25 am Unchanged | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management LP | 4,420,349 9.2% | 0 (Unchanged) | View |
| 2023-02-10 3:51 pm Purchase | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management LP | 4,420,349 9.2% | 4,420,349 (New Position) | View |
| 2023-02-10 1:20 pm Purchase | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management LP | 1,409,098 5.1% | 1,409,098 (New Position) | View |
| 2023-02-10 1:18 pm Purchase | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management LP | 40,423,832 5% | 40,423,832 (New Position) | View |
| 2023-02-10 1:16 pm Purchase | 13G | Burning Rock Biotech Limited BNR | Kynam Capital Management LP | 7,391,581 8.4% | 7,391,581 (New Position) | View |